Skip to content

Kestra Medical Technologies

US · KMTS #2924 by market cap Listed 2025
25.10 -1.53 -5.75%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions increased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.1 percentage points.

Ownership vs. money flow

Diverging

Institutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
106.26% -0.12pp
Institutions
144 +2
As of
2026/Q3 vs. prior period

Holder types

VC/PE Fund56.50%
Mutual Fund46.37%
Hedge Fund2.54%
Individual/Insider1.13%
Public Company0.56%
Government Pension Fund0.13%
Insurance Company0.13%

Top holders as of 2026-09-09

Bain Capital, LP 42.26% · 25.17M sh
FMR 10.00% · 5.96M sh
T. Rowe Price Group, Inc. 8.34% · 4.97M sh
Andera Partners 4.58% · 2.73M sh
Endeavour Vision SA 4.11% · 2.45M sh
Ally Bridge Group 3.83% · 2.28M sh
BlackRock 3.75% · 2.23M sh
Brown Advisory Incorporated 3.21% · 1.91M sh
AllianceBernstein 2.48% · 1.48M sh
Eventide Asset Management, LLC 2.43% · 1.45M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 8 buys · 42 sells

NameRoleStake
Bain Capital, LP -- 42.26%
Brian Webster Chief Executive Officer 0.52%
Traci Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director 0.25%
Alfred Ford Chief Commercial Officer 0.09%
Raymond Cohen Independent Director 0.08%
Mary Ladone Independent Director 0.06%
Timothy Moran Chief Business Officer 0.05%
Vaseem Mahboob Chief Financial Officer 0.03%
Jeffrey Schwartz Independent Chairperson 0.01%
Elizabeth Kwo Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-11-02 Timothy Moran Chief Business Officer Open Market Disposition -3,192 $29.56
2026-10-28 Vaseem Mahboob Chief Financial Officer Derivative Exercise and Sale -79,500 $17.00–30.60
2026-10-28 Vaseem Mahboob Chief Financial Officer Intent to Sell (Form 144) -4,788 $30.60
2026-10-27 Vaseem Mahboob Chief Financial Officer Intent to Sell (Form 144) -39,903 $30.48
2026-10-26 Traci Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director Intent to Sell (Form 144) -30,000 $30.03
2026-10-26 Traci Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director Derivative Exercise and Sale -30,000 $17.00–30.03
2026-10-26 Vaseem Mahboob Chief Financial Officer Intent to Sell (Form 144) -34,809 $30.04
2026-10-20 Traci Umberger Co-Founder, General Counsel, Chief Administrative Officer, Secretary & Director Derivative Exercise and Sale -100,000 $17.00–28.09
2026-10-19 Brian Webster Chief Executive Officer Automatic Disposition -15,000 $29.52–29.89
2026-09-29 Raymond Cohen Independent Director Open Market Disposition -3,330 $29.28
2026-09-20 Elizabeth Kwo Independent Director Open Market Disposition -4,010 $24.26
2026-09-08 Raymond Cohen Independent Director Other Acquisition +7,217 --
2026-09-08 Mary Ladone Independent Director Other Acquisition +7,217 --
2026-09-08 Conor Hanley Independent Director Other Acquisition +7,217 --
2026-09-08 Jeffrey Schwartz Independent Chairperson Other Acquisition +7,217 --
2026-09-08 Elizabeth Kwo Independent Director Other Acquisition +7,217 --
2026-09-08 Kevin Reilly Independent Director Other Acquisition +7,217 --
2026-09-07 Mary Ladone Independent Director Open Market Disposition -3,908 $25.20
2026-09-07 Conor Hanley Independent Director Open Market Disposition -5,694 $25.25
2026-09-07 Jeffrey Schwartz Independent Chairperson Open Market Disposition -3,890 $25.18

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Kestra Medical Technologies discussion 0 comments

Add a comment